Secretome of bovine umbilical vein endothelial cells promote wound healing regeneration on the second degree rat model burn injury.

Background: Burn injuries are an alarming indicator of the sensitivity of human tissue when confronted with high temperatures or chemicals. The current treatment for burn wounds needs to be improved and more extensive in scope. Significant research advances concerning the therapeutic potential of secretomes over the past two decades have expanded the range of therapies that utilize secretomes to encompass populations other than stem cells. Aim: This study details how the secretome extracted from the bovine umbilical vein endothelial cell (BUVEC) promotes the healing of burn injuries. Methods: The 48 rats were divided into four groups, namely the control group with povidone-iodine, the 5% BUVEC-conditioned medium (CM) cream group, the 10% BUVEC-CM cream group, the 15% BUVEC-CM cream group. Animals induced type II burns under anesthesia. Treatment is carried out topically, two times a day. Every day the wound was measured. The animals were put to sleep for samples on days 5, 13, 21, and 19. Samples in the form of skins were soaked in 4% paraformaldehyde and processed with paraffin-embedded for tissue preparations. The research results were processed using two way ANOVA. Results: The study showed that on day 5, wound closure occurred, whereas in the povidone-iodine group, macroscopically, the wound closed faster. Epithelial repair, increased fibroblasts and collagen, and blood vessel formation greatly increased in the 15% BUVEC-CM group on days 13, 21, and 29. Conclusion: Taken together, BUVEC secretome promoted fibroblast regeneration, collagen formation, re-epithelialization, and hair follicle regeneration on the burn injury wound healing.

In Vitro Neuroprotective Effect of the Bovine Umbilical Vein Endothelial Cell Conditioned Medium Mediated by Downregulation of IL-1ß, Caspase-3, and Caspase-9 Expression.

Mesenchymal stem cells (MSCs) and conditioned medium (CM) derived from human umbilical blood cord stem cells (HUBSC) are now being extensively utilized. Human umbilical vein endothelial cells (HUVECs) have the same ability as HUBSC as an option for autologous therapy. In addition, cell therapy using HUVECs may produce protective signals for cerebral vessels and promote neuronal survival after hypoxic-ischemic damage. HUVECs have the same anatomical and physiological structure as bovine umbilical vein endothelial cells (BUVECs). In this study, we aim to determine the ability of BUVEC-CM to reduce inflammation and apoptosis on in vitro neurodegeneration models (PC12 and SH-SY5Y cell lines). BUVEC-CM obtained from the third and fourth passages were analyzed using liquid chromatography-mass spectrometry (LC-MS) and high-resolution mass spectrometry (HR-MS), while the other part was used as a treatment for in vitro model neurodegeneration. The PC12 and SH-SY5Y cell lines were cultured and grouped into seven different treatments, including untreated cells. As the treatment group, cells were given TMT 10 µM in the presence of different doses of CM (25%, 50%, 75%, and 100%); as a control comparison of recent therapy, donepezil was used. In addition, cells with the administration of TMT 10 µM were run as a positive control. Cell viability assay (CCK-8) and enzyme-linked immunosorbent assay (ELISA) were performed to identify the viability and expression of interleukin-1ß (IL-1ß), caspase-3, and caspase-9 for both PC12 and SH-SY5Y cells. The results showed that BUVEC-CM could significantly reduce IL-1ß expression and downregulate caspase-3 and caspase-9, as well as when compared to the donepezil group. Taken together, these results indicate that BUVEC-CM can be used as a potential candidate for neuroprotective agents by reducing the activity of IL-1ß and the expression of caspase-9 and caspase-3 in PC12 and SH-SY5Y cells induced by TMT. However, further research still needs to be conducted.

Haematological profiles of Indonesian fat-tailed sheep under different physiological conditions.

The aim of this research was to evaluate the effect of sex, age, feed and physiological conditions on the haematological profiles of Indonesian fat-tailed sheep. A total of 32 healthy Indonesian fat-tailed sheep in different physiological states (i.e. suckling lambs/weaners aged 1-5 months, postweaning lambs aged 6-8 months, lactating ewes, rams, and pregnant ewes) were used in this study. Blood samples were collected from the jugular vein and then transferred into tubes for haematological analysis. The results revealed the following: RBCs, 7.09 ± 0.52 million µL-1; HCT, 46.76 ± 4.30%; Hb, 9.83 ± 0.57 g dL-1; MCV, 69.88 ± 5.48 fL; MCH, 14.94 ± 0.71 pg; MCHC, 24.29 ± 1.36 g dL-1; WBCs, 5.60 ± 1.24 thousand µL-1; percentage of neutrophils, 58.30 ± 7.31%; percentage of lymphocytes, 41.63 ± 7.31%; and N/L ratio, 0.18 ± 0.05. The physiological status of the sheep affected RBCs, Hb, HCT and MCH (P < 0.05). The sex, age, feed and physiological status of the animals should be considered in the interpretation of haematological profiles in Indonesian fat-tailed sheep.